Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06446869Not ApplicableRecruiting

Menopausal Symptoms Probiotic Study

Role: lead

NCT05762432Not ApplicableRecruiting

Diabetic Foot Ulcer Research Study

Role: lead

NCT05903612Withdrawn

Allergic Bronchopulmonary Aspergillosis Prescreening Study

Role: lead

NCT03187457Not ApplicableCompleted

PreFem: "What Happens to the Vaginal Microbiota When a BV Infection is Treated With Metronidazole?"

Role: collaborator

NCT00785434Phase 4Completed

Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD

Role: lead

All 5 trials loaded